Results 1 to 10 of about 52,847 (109)

Association of C-reactive protein–triglyceride glucose index with anxiety in American adults: outcomes from NHANES 2007 to 2010 [PDF]

European Journal of Medical Research
Background The novel serum C-reactive protein–triglyceride glucose index (CTI) represents a novel integrative biomarker for inflammation and insulin resistance. Despite this, its association with anxiety status remains underexplored.
Chao Jiang, Zhenbin Zheng, Yingcheng Su, Wei Fu, Quan Zhong   +4 more
doaj   +3 more sources

C-reactive protein-triglyceride glucose index and heart failure in US adults from NHANES 2001–2010 [PDF]

Scientific Reports
The C-reactive protein(CRP)-triglyceride glucose index (CTI) is a new composite biomarker used to assess inflammation and insulin resistance(IR) severity.
Ningyi Cheng, Zhicheng Ma, Yukun Chen, Lei Jin, Liangwan Chen   +4 more
doaj   +3 more sources

Nonlinear Association Between the C-Reactive Protein–Triglyceride–Glucose Index and Rheumatoid Arthritis Risk: The Mediating Role of Body Mass Index [PDF]

Mediators of Inflammation
Background Rheumatoid arthritis (RA) is a growing public health concern with rising incidence worldwide. The C‐reactive protein–triglyceride–glucose index (CTI), a composite marker of inflammation and insulin resistance, has been linked to various metabolic disorders, but its role in RA remains unclear.
Haiping Xie, Qinwen Liu, Xuefeng Xu, Yanfang Wu, Jianwen Liu, DianTian Lin, Meng Zhou, Zhihan Chen, Fei Gao, Liangchun Cai   +9 more
doaj   +3 more sources

Relationship between C-reactive protein triglyceride glucose index and cardiovascular disease risk: a cross-sectional analysis with machine learning [PDF]

BMC Medical Informatics and Decision Making
Background Cardiovascular disease (CVD) continues to be a leading cause of disease burden and mortality worldwide. Identifying reliable biomarkers for CVD risk assessment is essential.
Ruwen Zheng, Tianyi Wang, Min Liu, Xuedan Cao   +3 more
doaj   +3 more sources

C-reactive protein–triglyceride glucose index and stroke risk in early cardiovascular-kidney-metabolic syndrome: a National cohort study [PDF]

BMC Cardiovascular Disorders
Background The C-reactive protein–triglyceride glucose index (CTI) has been associated with stroke risk in prior studies. However, its relevance among individuals with cardiovascular-kidney-metabolic (CKM) syndrome remains uncertain.
Yinsong Xu, Shiqin Chen, Jingying Zhu, Qingyuan Wang, Weiyu Li, Gonghua Pan, Tian Lv, Youhua Huang, Wenbo Qu   +8 more
doaj   +4 more sources

Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals [PDF]

Cardiovascular Diabetology
Background The C-reactive protein–triglyceride glucose index (CTI) integrates inflammatory and metabolic markers and is closely associated with the incidence of coronary heart disease (CHD) and hypertension.
Yafang Chen, Wenjun Jia, Jianmin Guo, Han Yang, Xi Sheng, Liping Wei, Jiao Li   +6 more
doaj   +4 more sources

C-reactive protein-triglyceride glucose index predicts stroke incidence in a hypertensive population: a national cohort study [PDF]

Diabetology & Metabolic Syndrome
Background Both the triglyceride-glucose (TyG) index, a predictor of insulin resistance (IR), and inflammation are risk factors for stroke in hypertensive patients. However, only a handful of studies have coupled the TyG index and inflammation indices to
Songyuan Tang, Han Wang, Kunwei Li, Yaqing Chen, Qiaoqi Zheng, Jingjing Meng, Xin Chen   +6 more
doaj   +4 more sources

The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS) [PDF]

Cardiovascular Diabetology
Objective Chronic inflammation and metabolic dysregulation are key drivers of cardiovascular disease (CVD). Although the triglyceride-glucose (TyG) index and C-reactive protein (CRP) have each been associated with cardiovascular risk, their combined use ...
Lin Zhang, Shan Li, Dan Liu, JiaJia Gui, Jing Hu, Qian Wang, Wei Mao   +6 more
doaj   +4 more sources

C-reactive protein–triglyceride glucose index predicts mortality in cardiovascular-kidney-metabolic syndrome stage 0–3: a prospective cohort study [PDF]

Diabetology & Metabolic Syndrome
Background Cardiovascular-kidney-metabolic (CKM) syndrome is defined by the interplay of metabolic risk factors, chronic kidney disease, and cardiovascular disease.
Qianliang Ying, Fan He, Lunzhe Wu, Qucheng Wei, Jian Xu   +4 more
doaj   +4 more sources

Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study [PDF]

Cardiovascular Diabetology
Background The C-reactive protein-triglyceride-glucose index (CTI) has emerged as an innovative composite marker for evaluating metabolic-inflammatory dysregulation, integrating markers of insulin resistance and systemic inflammation.
Yu Sun, Yu Guo, Shiyin Ma, Zhi Mao, Deguo Meng, Kaige Xuan, Ruogu Lu, Xudong Pan, Xiaoyan Zhu   +8 more
doaj   +4 more sources